Goff Debra A, Karam George H, Haines Stuart T
College of Pharmacy, Ohio State University, and Wexner Medical Center, Columbus, OH
Louisiana State University School of Medicine, New Orleans, LA.
Am J Health Syst Pharm. 2017 Feb 15;74(4):224-231. doi: 10.2146/ajhp160379. Epub 2017 Jan 12.
The impact of an interprofessional mentoring program to advance antimicrobial stewardship programs (ASPs) in selected U.S. hospitals and lessons learned are described.
A seven-step mentoring process with self-assessment, telephone calls, continuing education, a one-day onsite visit, action plan, and outcome data collection and analysis was provided to ASP teams at nine hospitals. Six hospitals completed the program. A significant improvement in the timeliness and appropriateness of i.v. antibiotic therapy (defined as a hang time within one hour after prescriber order entry and broad-spectrum coverage for gram-negative pathogens administered first when combination therapy was used) was observed in patients with sepsis over the 12-month period after implementation of the mentoring program. As a result of requiring hospital administration's participation in the mentoring program, increased funding became available at three hospitals for the microbiology laboratory to provide new rapid diagnostic tests and for pharmacist and physician time to devote to ASP activities. The collaboration and engagement of ASP team members, inclusion of hospital administrators and pharmacy directors in the onsite mentoring visits, and an experienced mentor team with an infectious diseases (ID) physician and ID pharmacist contributed to ASP success. Challenges included insufficient time to collect outcome metrics due to competing hospital priorities and loss of momentum over time.
A mentoring program for antimicrobial stewardship provided the perspective that comes from experience. Engagement of hospital administration was a key factor for both developing and sustaining a stewardship program.
描述一项跨专业指导计划对美国部分医院推进抗菌药物管理计划(ASP)的影响及经验教训。
为9家医院的ASP团队提供了一个七步指导流程,包括自我评估、电话沟通、继续教育、为期一天的现场访问、行动计划以及结果数据收集与分析。6家医院完成了该计划。在实施指导计划后的12个月期间,脓毒症患者静脉用抗生素治疗的及时性和合理性(定义为在医嘱录入后1小时内开始用药,联合治疗时首先使用对革兰氏阴性病原体的广谱覆盖药物)有显著改善。由于要求医院管理层参与指导计划,3家医院有了更多资金,用于微生物实验室提供新的快速诊断检测,以及药剂师和医生投入到ASP活动的时间。ASP团队成员的协作与参与、医院管理人员和药房主任参与现场指导访问,以及由一名传染病医生和一名传染病药剂师组成的经验丰富的指导团队促成了ASP的成功。挑战包括由于医院其他优先事项的竞争而没有足够时间收集结果指标,以及随着时间推移动力丧失。
抗菌药物管理指导计划提供了来自经验的视角。医院管理层的参与是制定和维持管理计划的关键因素。